Genedata Screener 7.0 High Throughput Screening (HTS) and High Content Screening (HCS) Analysis Platform Released

Basel, Switzerland, April 21, 2009

Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, today announced the release of Genedata Screener®7.0, the latest version of its open and scalable enterprise solution for high throughput screening (HTS) and high content screening (HCS) analysis. Screener 7.0 combines an enterprise-wide assay data management platform with high-performance processing workflows and flexible analysis tools and provides access to high content screening-specific functionality.

Screener 7.0 can be easily integrated with any plate-based high content screening (HCS) instrument or image analysis software, including image databases via the HCS Image API. Currently it is fully compatible with the Thermo Scientific Cellomics Store image management system and integration with additional platform technology providers will follow.

Other features improve Screener’s support of complex, multiplexed assay formats and technologies, such as HCS, label-free and multiplex target assays. Data from multiple read-outs can easily be compared and combined both visually and statistically, in scatter and distribution plots, statistical tables, and user-definable calculations across read-outs. New functionality also enables the consistent generation of hit lists from such assays, exploiting their multiple read-outs in a concise fashion, documenting the criteria applied and managing the results centrally for shared access.

“Genedata Screener has a history of providing the most statistically sound processing of extremely large and complex data sets and yet retains a very user-friendly interface for visualization, management and review,” said Dr. Othmar Pfannes, CEO of Genedata. “As we enter the realm of increasingly complex time series and high content assay data, Genedata is proud to remain at the forefront of technology innovation.”

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US. www.genedata.com

 

Contact
Allison Kurz
Genedata
Marketing & Communications
Phone: +41 61 511 8459
communications@genedata.com

Jackie Thrasivoulos
Genedata
Public Relations
Phone: +1 508 881 3109
jackie.thrasivoulos@genedata.com

Disclaimer

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.